Robert Pirker
Medical University of Vienna, Vienna, Austria
Robert Pirker was Professor of Medicine at the Department of Medicine I, Medical University of Vienna, Austria. Since his retirement from the General Hospital of Vienna in 2018, he has been working in private practice in Vienna and has continued teaching Medical Oncology at the Medical University of Vienna. He is the current President of the Central European Lung Cancer Association.
Robert Pirker obtained a master’s degree in Biochemistry and a doctor’s degree in Medicine from the University of Vienna. He trained in Internal Medicine, Hemato-Oncology and Nuclear Medicine at the University of Vienna. He also worked as NIH Visiting Fellow at the Laboratory of Molecular Biology (Chief: Dr. Ira Pastan), National Cancer Institute, Bethesda, MD, USA (1983-86).
His research has focused on antibody-toxin conjugates, drug resistance mechanisms including predictive factors in patients with cancer, therapy of lung cancer and anemia management in cancer patients. He has published more than 220 articles, reviews or book chapters. According to Google Scholar (December 5, 2022), he has 26224 citations and an h-index of 64. He was an ESMO Faculty Member on Chest Tumors (2006-2011), a member including chair of the Educational Committee of IASLC (2004-2011), and a member of the IASLC Board of Directors (2015-2019). He is on the Editorial Board of Lung Cancer and of Translational Lung Cancer Research. He has received several scientific awards and has been a member of many scientific societies including ESMO, IASLC, AACR and ASCO for many years.
Robert Pirker was Congress President of several Central European Lung Cancer Conferences, Chair of the Scientific Committee of the European Multidisciplinary Conference on Thoracic Oncology in 2009, Co-Organizer of the 10th Chinese-German Lung Cancer Forum in 2018, Conference President of the IASLC 17th World Conference on Lung Cancer in 2016 and Honorary Chair of the IASLC World Conference on Lung Cancer in 2022.
Editorial Board
Terms of Appointment: December 2013 - November 2019; December 2019 - November 2020; December 2020 - November 2022; December 2022 - November 2024; December 2024 - November 2026